glp-1 colorectal cancer death risk study november 2025 GLP-1s in Oncology: Exploring Risks and Potential Benefits Ozempic, Wegovy might lower colon GLP-1 receptor agonists and cancer:

Your skins main job is to be a barrier - to keep things out

This could be a big deal for companies that are selling protein shakes but not marketing directly for weight loss, products like Fairlife or Premier Protein ready-to-drink shakes could see big volume increases potentially as market penetration increases and insurance coverage becomes more broad

These FDA-approved dosing schedules represent standard protocols, though individual patient circumstances may necessitate modifications under physician guidance

De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrm E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis

Furthermore, the EMA has withdrawn the weight loss medication rimonabant, a selective cannabinoid type 1 receptor antagonist, due to its reported links to increased risks of depression and suicide [70]